288 related articles for article (PubMed ID: 11045431)
41. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
Flotte TR
Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
[TBL] [Abstract][Full Text] [Related]
42. [Gene transfer to airway epithelial cells: current status and future direction].
Setoguchi Y; Noto K; Iwakami S; Tajima M; Kira S
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32 Suppl():86-95. PubMed ID: 7602850
[TBL] [Abstract][Full Text] [Related]
43. Efficient gene transfer to airway epithelium using recombinant Sendai virus.
Yonemitsu Y; Kitson C; Ferrari S; Farley R; Griesenbach U; Judd D; Steel R; Scheid P; Zhu J; Jeffery PK; Kato A; Hasan MK; Nagai Y; Masaki I; Fukumura M; Hasegawa M; Geddes DM; Alton EW
Nat Biotechnol; 2000 Sep; 18(9):970-3. PubMed ID: 10973218
[TBL] [Abstract][Full Text] [Related]
44. High-efficiency transfer of cystic fibrosis transmembrane conductance regulator cDNA into cystic fibrosis airway cells in culture using lactosylated polylysine as a vector.
Kollen WJ; Mulberg AE; Wei X; Sugita M; Raghuram V; Wang J; Foskett JK; Glick MC; Scanlin TF
Hum Gene Ther; 1999 Mar; 10(4):615-22. PubMed ID: 10094204
[TBL] [Abstract][Full Text] [Related]
45. A comparison of linear and branched polyethylenimine (PEI) with DCChol/DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo.
Wiseman JW; Goddard CA; McLelland D; Colledge WH
Gene Ther; 2003 Sep; 10(19):1654-62. PubMed ID: 12923564
[TBL] [Abstract][Full Text] [Related]
46. Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.
Zhang LN; Karp P; Gerard CJ; Pastor E; Laux D; Munson K; Yan Z; Liu X; Godwin S; Thomas CP; Zabner J; Shi H; Caldwell CW; Peluso R; Carter B; Engelhardt JF
Mol Ther; 2004 Dec; 10(6):990-1002. PubMed ID: 15564131
[TBL] [Abstract][Full Text] [Related]
47. Enhanced efficiency of lactosylated poly-L-lysine-mediated gene transfer into cystic fibrosis airway epithelial cells.
Kollen WJ; Schembri FM; Gerwig GJ; Vliegenthart JF; Glick MC; Scanlin TF
Am J Respir Cell Mol Biol; 1999 May; 20(5):1081-6. PubMed ID: 10226080
[TBL] [Abstract][Full Text] [Related]
48. Cationic lipid:pDNA complexes for the treatment of cystic fibrosis.
Eastman SJ; Scheule RK
Curr Opin Mol Ther; 1999 Apr; 1(2):186-96. PubMed ID: 11715942
[TBL] [Abstract][Full Text] [Related]
49. RT-PCR method specific for the detection of transgenic CFTR mRNA in the presence of transgene plasmid DNA and endogenous CFTR mRNA.
Mayall ES; Coutelle C
Gene Ther; 1997 Aug; 4(8):875-8. PubMed ID: 9338018
[TBL] [Abstract][Full Text] [Related]
50. Technology evaluation: cystic fibrosis therapy, Genzyme.
Cockett MI
Curr Opin Mol Ther; 1999 Apr; 1(2):279-83. PubMed ID: 11715952
[TBL] [Abstract][Full Text] [Related]
51. Insertion of natural intron 6a-6b into a human cDNA-derived gene therapy vector for cystic fibrosis improves plasmid stability and permits facile RNA/DNA discrimination.
Boyd AC; Popp F; Michaelis U; Davidson H; Davidson-Smith H; Doherty A; McLachlan G; Porteous DJ; Seeber S
J Gene Med; 1999; 1(5):312-21. PubMed ID: 10738548
[TBL] [Abstract][Full Text] [Related]
52. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
[TBL] [Abstract][Full Text] [Related]
53. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis.
Noone PG; Hohneker KW; Zhou Z; Johnson LG; Foy C; Gipson C; Jones K; Noah TL; Leigh MW; Schwartzbach C; Efthimiou J; Pearlman R; Boucher RC; Knowles MR
Mol Ther; 2000 Jan; 1(1):105-14. PubMed ID: 10933918
[TBL] [Abstract][Full Text] [Related]
54. Potocytosis and cellular exit of complexes as cellular pathways for gene delivery by polycations.
Grosse S; Aron Y; Thévenot G; François D; Monsigny M; Fajac I
J Gene Med; 2005 Oct; 7(10):1275-86. PubMed ID: 15906406
[TBL] [Abstract][Full Text] [Related]
55. Transfection efficiency and uptake process of polyplexes in human lung endothelial cells: a comparative study in non-polarized and polarized cells.
Mennesson E; Erbacher P; Piller V; Kieda C; Midoux P; Pichon C
J Gene Med; 2005 Jun; 7(6):729-38. PubMed ID: 15759254
[TBL] [Abstract][Full Text] [Related]
56. Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice.
Cmielewski P; Donnelley M; Parsons DW
J Gene Med; 2014; 16(9-10):291-9. PubMed ID: 25130650
[TBL] [Abstract][Full Text] [Related]
57. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo.
Ferrari S; Moro E; Pettenazzo A; Behr JP; Zacchello F; Scarpa M
Gene Ther; 1997 Oct; 4(10):1100-6. PubMed ID: 9415317
[TBL] [Abstract][Full Text] [Related]
58. Nuclear translocation of lactosylated poly-L-lysine/cDNA complex in cystic fibrosis airway epithelial cells.
Klink DT; Chao S; Glick MC; Scanlin TF
Mol Ther; 2001 Jun; 3(6):831-41. PubMed ID: 11407896
[TBL] [Abstract][Full Text] [Related]
59. Update on gene therapy for cystic fibrosis.
Griesenbach U; Geddes DM; Alton EW
Curr Opin Mol Ther; 2003 Oct; 5(5):489-94. PubMed ID: 14601517
[TBL] [Abstract][Full Text] [Related]
60. Regulated expression of the human CFTR gene in epithelial cells.
Ye L; Chan S; Chow YH; Tsui LC; Hu J
Mol Ther; 2001 May; 3(5 Pt 1):723-33. PubMed ID: 11356077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
